IQV

SELL

IQVIA Holdings, Inc.

Healthcare · Rank #239 · Analyzed Oct 18, 2026

$266.90

Current Price

$70.18

Intrinsic Value

-73.7%

Upside/Downside

2.5/10

Score

2.5/5

Quality

Analysis Summary

Valuation Consensus0/2 methods agree

Quality Score2.5/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 73.7%

Fair Value Range

Low$42.45

Base (IV)$70.18

High$103.34

Entry Points

Conservative$29.72

Moderate$42.45

Aggressive$49.13

Quality & Moat Breakdown

Return on Equity22.8% → 1.0/1.0

Debt LevelD/E 258 → 0/1.0

Revenue QualityGrowth 8.5%, margin Δ-3.7% +recovery → 1.0/1.0

Moat Strength1.5/5 → 0/1.0

Profit Margins8.1% → 0.5/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.